Biodel Inc. is Today’s Focus Stock on MicroStockProfit.com
DALLAS — MicroStockProfit.com announces an investment report featuring Biodel Inc. . The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Read more on GlobeNewswire via Yahoo! Finance
Analyst Research on Sequenom Inc. and Life Technologies Corporation – Genetic Sequencing Could Take Off in 2011
JOHANNESBURG, SOUTH AFRICA–(Marketwire – 01/14/11) – www.stockcall.com/ offers investors comprehensive research on the biotechnology industry and has completed analytical research on Sequenom Inc. (NASDAQ: SQNM – News ) and Life Technologies Corporation (NASDAQ: LIFE – News ). Register with us today at www.stockcall.com/ to have free access …
Read more on Marketwire via Yahoo! Finance
Global Human Vaccines Market to Reach US$25 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
GIA announces the release of a comprehensive global report on Human Vaccines market.
Read more on PRWeb via Yahoo! News
Marina Biotech, Inc. Announces Revised Third Quarter 2010 Financial Results
BOTHELL, WA–(Marketwire – November 15, 2010) – Marina Biotech, Inc. ( NASDAQ : MRNA ), a leading RNAi-based drug discovery and development company, today reported revised financial results for the third quarter and nine months ended September 30, 2010.
Read more on Marketwire
CEO And President Interview: Cleveland BioLabs, Inc. (CBLI) – Dr. Michael Fonstein
67 WALL STREET, New York – November 15, 2010 – The Wall Street Transcript has just published its Medical Research, Diagnostic Substances & Life Science Tools Report offering a timely review of the sector to serious investors and industry executives. This Special feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers …
Read more on Wall Street Transcript via Yahoo! Finance
Oligomerix, Inc. Awarded Phase II NIH Grant To Discover Novel Drugs For Alzheimer’s Disease
Oligomerix, Inc. announced the receipt of a two-year Small Business Innovation Research (SBIR) Phase II grant for $1.6M from the National Institute on Aging, National Institutes of Health (NIH), for a program to discover small molecules and antibodies targeting tau protein oligomers in the development of disease modifying therapeutics for Alzheimer’s disease. Compound libraries will be screened …
Read more on Medical News Today
Marina Biotech, Inc. Announces Third Quarter 2010 Financial Results
Highlights Third Quarter and Recent Corporate Accomplishments
Read more on Marketwire
Dr. Maxine Gowen, Wharton ’02 and CEO of Trevena, Inc., to Speak on “Big Pharma vs. Biotech: Innovation in an Era of …
PHILADELPHIA, PA–(Marketwire – 11/05/10) – Dr. Maxine Gowen, Chief Executive Officer of Trevena, Inc., will be presenting on the topic of innovation in the pharmaceutical industry and the changing relationship between big pharma and biotech. Dr. Gowen remarked: “We are witnessing the adoption of the biotech culture by the world’s leading pharmaceutical companies, in an effort to accelerate …
Read more on Marketwire via Yahoo! Finance
Oncolytics Biotech® Inc. Collaborators Present Data from U.K. Translational Colorectal Cancer Study at the …
Oncolytics Biotech Inc.
Read more on PR Newswire via Yahoo! Finance
GeneLink BioSciences, Inc. Ranked 62nd Fastest Growing Company in North America on Deloitte’s 2010 Technology Fast 500
GeneLink BioSciences, Inc. , a leading consumer genomics biotech company, today announced that it ranked number 62 on Technology Fast 500â¢, Deloitte’s ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America.  Rankings are based on percentage of fiscal year growth during the period from 2005-2009.  GeneLink grew …
Read more on PR Newswire via Yahoo! Finance
Powered by Yahoo! Answers
